It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Patent case: Inventor Holdings, LLC v. Bed Bath & Beyond, Inc., USA
-
Patent case: Eli Lilly and Company vs. Fresenius Kabi Nederland B.V., Netherlands
-
European Union, Patents, Pharma, Pharmaceutical patent, Plausibility, Second Medical Use, SPC, United Kingdom
Third Party SPC – Question Referred
-
The Price You Pay
-
‘UK should postpone ratification of Unified Patent Court Agreement’
-
Lithuanian parliament approves ratification bill Unified Patent Court Agreement
-
Schütz (UK) Limited v Werit UK Limited and another [2011] EWCA Civ 1337
-
Top 3 posts of the autumn from our IP law blogs
-
Submission of a tender: imminent infringement?
-
Patent case: Glasswall Solutions Ltd. v. Clearswift Ltd., USA